NCT02155790View on ClinicalTrials.gov

The Peregrine Study: A Safety and Performance Study of Renal Denervation

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

September 4, 2017

Conditions
Hypertension
Interventions
DEVICE

The Peregrine System Infusion Catheter

The ASI catheter is inserted bilaterally into the renal arteries and a specified amount of a neurolytic agent is inserted into the vessel walls.

Trial Locations (3)

15030

Na Homolce Hospital, Prague

Unknown

American Heart of Poland, Tychy

43-450

American Heart of Poland, Ustroń

Sponsors
All Listed Sponsors
lead

Ablative Solutions, Inc.

INDUSTRY

NCT02155790 - The Peregrine Study: A Safety and Performance Study of Renal Denervation | Biotech Hunter | Biotech Hunter